Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?

Anesthesiology

Volumn 118, Issue 2, 2013, Pages 382-386

  Nuttall, Gregory A ^a   Malone, Ann M ^b   Michels, Carrie A ^b   Trudell, Laurie C ^b   Renk, Tricia D ^b   Marienau, Mary E Shirk ^b   Oliver, William C ^a   Ackerman, Michael J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b Mayo School of Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PALLIATIVE THERAPY; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QT INTERVAL; RETROSPECTIVE STUDY; SIDE EFFECT; SUDDEN DEATH; SURGICAL PATIENT; TORSADE DES POINTES; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; DATABASES, FACTUAL; DROPERIDOL; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TACHYCARDIA, VENTRICULAR; TORSADES DE POINTES;

EID: 84872870753     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31827dde8d     Document Type: Article

References (11)

1. Glassman AH, Bigger JT Jr: Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158:1774-82
2. White PF: Droperidol: A cost-effective antiemetic for over thirty years. Anesth Analg 2002; 95:789-90
3. McKeage K, Simpson D, Wagstaff AJ: Intravenous droperidol: A review of its use in the management of postoperative nausea and vomiting. Drugs 2006; 66:2123-47
4. Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J: Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102:1094-100
5. Ludwin DB, Shafer SL: Con: The black box warning on droperidol should not be removed (but should be clarified!). Anesth Analg 2008; 106:1418-20
6. Habib AS, Gan TJ: Food and drug administration black box warning on the perioperative use of droperidol: A review of the cases. Anesth Analg 2003; 96:1377-9
7. Schaub I, Lysakowski C, Elia N, Tramèr MR: Low-dose droperidol (≤1 mg or ≤15 μg kg-1) for the prevention of postoperative nausea and vomiting in adults: Quantitative systematic review of randomised controlled trials. Eur J Anaesthesiol 2012; 29:286-94
8. Nuttall GA, Eckerman KM, Jacob KA, Pawlaski EM, Wigersma SK, Marienau ME, Oliver WC, Narr BJ, Ackerman MJ: Does low-dose droperidol administration increase the risk of druginduced QT prolongation and torsade de pointes in the general surgical population? Anesthesiology 2007; 107:531-6
9. Charbit B, Alvarez JC, Dasque E, Abe E, Démolis JL, Funck-Brentano C: Droperidol and ondansetron-induced QT interval prolongation: A clinical drug interaction study. Anesthesiology 2008; 109:206-12
10. White PF, Song D, Abrao J, Klein KW, Navarette B: Effect of low-dose droperidol on the QT interval during and after general anesthesia: A placebo-controlled study. Anesthesiology 2005; 102:1101-5
11. Mehta D, Sanatani S, Whyte SD: The effects of droperidol and ondansetron on dispersion of myocardial repolarization in children. Paediatr Anaesth 2010; 20:905-12